Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia.
BACKGROUND
Non-compliance with childhood acute lymphoblastic leukemia (ALL) protocol is an important determinant of poor treatment outcome. Non-compliance with protocol may not only concern parents or patients, but may also concern health-care providers (HCP). Our study examines the accuracy of leukemia risk classification and attitude of HCP toward protocol compliance in Indonesia.


METHODS
A combined retrospective study of medical records (MR) and a cross-sectional questionnaire study with HCP were conducted. Accurate ALL risk classification in MR was assessed. HCP' knowledge of risk classification and their attitude toward protocol compliance were examined.


RESULTS
A total of 164 MR patients with ALL were assessed and 97 HCP were interviewed. The protocol criteria for high-risk (HR) were not complete in 82 MR (50%). Of 97 HCP, 95% did not mention all five protocol criteria for HR. Both in the MR as well as in the questionnaires lymphoblast count on day 8 of chemotherapy, as early response to treatment, was the most frequently missed item (missing in 35% of MR and 85% of questionnaires). Only 14% of respondents actually checked with parents whether they administered the prescribed medicines.


CONCLUSIONS
Our study shows that HCP should improve their knowledge and assessment of childhood ALL risk classification, especially lymphoblast count on day 8 of chemotherapy. Proper risk classification and subsequent correct treatment may enable more children to be cured of leukemia.
Sitaresmi
Mei Neni
MN
Department of Growth and Development Pediatrics, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia. msitaresmi@yahoo.com
Mostert
Saskia
S
Gundy
Chad M
CM
Sutaryo
Veerman
Anjo J P
AJ
D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D003695:Delivery of Health Care / Q000592:standards*; D019983:Guideline Adherence / Q000592:standards*; D006282:Health Personnel / Q000592:standards*; D006801:Humans; D007214:Indonesia / Q000453:epidemiology; D007223:Infant; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000453:epidemiology / Q000628:therapy*; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D011795:Surveys and Questionnaires